Literature DB >> 26167777

Annual diabetic eye examinations in a managed care Medicaid population.

Elham Hatef1, Bruce G Vanderver, Peter Fagan, Michael Albert, Miriam Alexander.   

Abstract

OBJECTIVES: To assess how well a managed care organization performed annual diabetic eye screening in a Medicaid population, and to identify barriers to completion. STUDY
DESIGN: Cross-sectional study.
METHODS: Healthcare claims data for all Medicaid patients with diabetes covered by Priority Partners Managed Care Organization in 2010 and 2012 were collected, and the annual rates for diabetic eye exams in those years were reported. Predictors of completion of the diabetic eye exam in primary care clinics in 2010 and 2012 were assessed using a logistic regression model.
RESULTS: We identified 8902 Medicaid patients with a diagnosis of diabetes using the Healthcare Effectiveness Data and Information Set codes: 3838 patients in 2010 and 5064 patients in 2012. In 2010 and 2012, 46% and 64% of patients, respectively, had completed their annual diabetic eye exam. The increase in participation in annual eye exams from 2010 to 2012 was statistically significant (P < .001). Among the factors increasing the likelihood of completion of an annual diabetic eye exam among the Medicaid population were access to a nonmydriatic fundoscopic camera in the primary care clinic, compliance with glycated hemoglobin measurement based on the recommended guidelines, incentives offered to primary care offices, and higher resource utilization band score. Financial incentives to patients, however, lowered the completion rate.
CONCLUSIONS: Annual diabetic eye exam completion is low among the Medicaid population. Detecting high-risk patients and adjusting for factors that play a role in nonadherence both increase the rate of annual diabetic eye exams among underserved populations such as Medicaid patients.

Entities:  

Mesh:

Year:  2015        PMID: 26167777

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  8 in total

1.  Assessing the utility of 2.5% phenylephrine for diagnostic pupillary dilation.

Authors:  James C Liu; Wesley Green; Gregory P Van Stavern; Susan M Culican
Journal:  Can J Ophthalmol       Date:  2017-08       Impact factor: 1.882

2.  Factors Associated with Adherence to Screening Guidelines for Diabetic Retinopathy Among Low-Income Metropolitan Patients.

Authors:  Jessica Kuo; James C Liu; Ella Gibson; P Kumar Rao; Todd P Margolis; Bradley Wilson; Mae O Gordon; Emily Fondahn; Rithwick Rajagopal
Journal:  Mo Med       Date:  2020 May-Jun

Review 3.  Diabetic Eye Screening: Knowledge and Perspectives from Providers and Patients.

Authors:  Yao Liu; Rebecca Swearingen
Journal:  Curr Diab Rep       Date:  2017-08-31       Impact factor: 4.810

4.  Comparison of Access to Eye Care Appointments Between Patients With Medicaid and Those With Private Health Care Insurance.

Authors:  Yoon H Lee; Andrew X Chen; Varshini Varadaraj; Gloria H Hong; Yimin Chen; David S Friedman; Joshua D Stein; Nicholas Kourgialis; Joshua R Ehrlich
Journal:  JAMA Ophthalmol       Date:  2018-06-01       Impact factor: 7.389

5.  Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes.

Authors:  William S Gange; Jennifer Lopez; Benjamin Y Xu; Khristina Lung; Seth A Seabury; Brian C Toy
Journal:  Diabetes Care       Date:  2021-09-02       Impact factor: 19.112

6.  Financial disincentives? A three-armed randomised controlled trial of the effect of financial Incentives in Diabetic Eye Assessment by Screening (IDEAS) trial.

Authors:  Gaby Judah; Ara Darzi; Ivo Vlaev; Laura Gunn; Derek King; Dominic King; Jonathan Valabhji; Colin Bicknell
Journal:  Br J Ophthalmol       Date:  2018-05-23       Impact factor: 4.638

7.  A 15 month experience with a primary care-based telemedicine screening program for diabetic retinopathy.

Authors:  James E Benjamin; Justin Sun; Devin Cohen; Joseph Matz; Angela Barbera; Jeffrey Henderer; Lorrie Cheng; Julia Grachevskaya; Rajnikant Shah; Yi Zhang
Journal:  BMC Ophthalmol       Date:  2021-02-04       Impact factor: 2.209

8.  Sex Disparities in Cardiovascular Risk Factor Assessment and Screening for Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review.

Authors:  Marit de Jong; Sanne A E Peters; Rianneke de Ritter; Carla J H van der Kallen; Simone J S Sep; Mark Woodward; Coen D A Stehouwer; Michiel L Bots; Rimke C Vos
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-30       Impact factor: 6.055

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.